Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Mar-23 4:29 PM View:  | Acorda Therapeutics, Inc. (ACOR) | 17-Mar-23 | Purchase | 10,000 | $0.65 | $6,500.00 | 7% 139.76K to 149.76K | |
| 20-Mar-23 4:29 PM View: | Acorda Therapeutics, Inc. (ACOR) | 16-Mar-23 | Private Purchase | 10,156 | $0.60 | $6,093.60 | 8% 129.6K to 139.76K | |
| 21-Mar-22 4:26 PM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Mar-22 | Sale | 2,289 | $1.70 | $3,894.50 | (2%) 131.89K to 129.6K | |
| 08-Sep-21 7:19 AM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Sep-21 | Payment of Exercise | 3,940 | $4.38 | $17,257.20 | (3%) 135.83K to 131.89K | 4% |
| 05-Mar-21 6:34 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Mar-21 | Grant | 29,000 | -- | -- | 27% 106.83K to 135.83K | |
| 21-Sep-20 8:29 AM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Sep-20 | Grant | 8,543 | -- | -- | 1% 632.44K to 640.98K | |
| 04-Dec-19 7:47 AM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Dec-19 | Market Sale (Planned) | 4,699 | $1.60 | $7,505.24 | (< 1%) 637.14K to 632.44K | 54% |
| 12-Mar-19 4:13 PM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Mar-19 | Grant | 25,629 | -- | -- | 4% 611.51K to 637.14K | |
| 25-Feb-19 4:11 PM View: | Acorda Therapeutics, Inc. (ACOR) | 21-Feb-19 | Payment of Exercise | 2,027 | $13.38 | $27,121.30 | (< 1%) 613.53K to 611.51K | 95% |
| 27-Dec-18 8:09 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-18 | Grant | 5,980 | -- | -- | < 1% 607.55K to 613.53K | |
| 06-Dec-18 8:00 AM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Dec-18 | Market Sale (Planned) | 3,620 | $20.60 | $74,554.30 | (< 1%) 611.17K to 607.55K | 96% |
| 07-Nov-18 4:02 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Nov-18 | Payment of Exercise | 2,031 | $20.28 | $41,188.70 | (< 1%) 613.21K to 611.17K | 96% |
| 12-Sep-18 4:09 PM View: | Acorda Therapeutics, Inc. (ACOR) | 10-Sep-18 | Grant | 5,980 | -- | -- | < 1% 607.23K to 613.21K | |
| 07-Mar-18 7:53 AM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Mar-18 | Payment of Exercise | 24,590 | $25.95 | $638,110.00 | (4%) 631.82K to 607.23K | 97% |
| 07-Mar-18 7:53 AM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Mar-18 | Option Exercise | 62,500 | $19.81 | $1,238,120.00 | 11% 569.32K to 631.82K | |
| 26-Feb-18 8:26 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Feb-18 | Grant | 14,727 | -- | -- | 3% 554.59K to 569.32K | |
| 20-Jun-17 3:52 PM View: | Acorda Therapeutics, Inc. (ACOR) | 16-Jun-17 | Market Purchase | 20,000 | $16.95 | $338,998.00 | 4% 534.59K to 554.59K | (96%) |
| 03-Mar-17 4:05 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Mar-17 | Grant | 11,960 | -- | -- | 2% 522.63K to 534.59K | |
| 16-Dec-16 8:08 AM View: | Acorda Therapeutics, Inc. (ACOR) | 14-Dec-16 | Option Exercise | 40,172 | $15.49 | $622,264.00 | 8% 522.63K to 562.8K | |
| 16-Dec-16 8:08 AM View: | Acorda Therapeutics, Inc. (ACOR) | 14-Dec-16 | Market Option Sale (Planned) | 40,172 | $20.75 | $833,655.00 | (7%) 562.8K to 522.63K | 96% |
| 05-Dec-16 5:08 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-16 | Market Sale (Planned) | 7,160 | $20.74 | $148,482.00 | (1%) 529.79K to 522.63K | 96% |
| 05-Feb-16 4:08 PM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Feb-16 | Option Exercise | 29,238 | $9.36 | $273,740.00 | 6% 500.55K to 529.79K | |
| 22-Jan-16 4:05 PM View: | Dyax Corp. (DYAXE.OB) | 22-Jan-16 | Disposition | 133,333 | -- | -- | (100%) 133.33K to 0 | |
| 19-Jan-16 4:22 PM View: | Dyax Corp. (DYAXE.OB) | 15-Jan-16 | Option Exercise | 133,333 | $7.66 | $1,021,320.00 | 100% 0 to 133.33K | |
| 03-Dec-15 4:37 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-15 | Market Sale (Planned) | 11,850 | $38.08 | $451,225.00 | (2%) 512.4K to 500.55K | 98% |
| 06-Oct-15 8:21 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Oct-15 | Option Exercise | 910 | $15.49 | $14,095.90 | < 1% 512.4K to 513.31K | |
| 06-Oct-15 8:21 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Oct-15 | Market Option Sale (Planned) | 910 | $30.10 | $27,391.00 | (< 1%) 513.31K to 512.4K | 98% |
| 06-Oct-15 8:21 PM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Oct-15 | Option Exercise | 134,090 | $9.78 | $1,311,690.00 | 26% 512.4K to 646.49K | |
| 06-Oct-15 8:21 PM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Oct-15 | Market Option Sale (Planned) | 134,090 | $28.01 | $3,756,140.00 | (21%) 646.49K to 512.4K | 97% |
| 06-Mar-15 6:24 PM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Mar-15 | Grant | 17,000 | -- | -- | 3% 495.4K to 512.4K | |
| 03-Dec-14 9:24 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-14 | Option Exercise | 51,265 | $8.14 | $417,297.00 | 11% 478.53K to 529.79K | |
| 03-Dec-14 9:24 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-14 | Market Option Sale (Planned) | 34,394 | $35.59 | $1,224,140.00 | (6%) 529.79K to 495.4K | 98% |
| 07-Mar-14 4:16 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Mar-14 | Grant | 17,786 | -- | -- | 4% 460.74K to 478.53K | |
| 04-Dec-13 4:53 PM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Dec-13 | Market Sale (Planned) | 18,125 | $33.52 | $607,468.00 | (4%) 478.87K to 460.74K | 98% |
| 20-Aug-13 5:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 20-Aug-13 | Option Exercise | 172,723 | $2.60 | $449,080.00 | 51% 338.09K to 510.81K | |
| 20-Aug-13 5:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 20-Aug-13 | Market Option Sale (Planned) | 31,945 | $34.35 | $1,097,440.00 | (6%) 510.81K to 478.87K | 98% |
| 20-Aug-13 5:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 19-Aug-13 | Option Exercise | 55,993 | $2.60 | $145,582.00 | 17% 338.09K to 394.08K | |
| 20-Aug-13 5:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 19-Aug-13 | Market Option Sale (Planned) | 55,993 | $34.02 | $1,904,880.00 | (14%) 394.08K to 338.09K | 98% |
| 20-Aug-13 5:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 16-Aug-13 | Option Exercise | 61,062 | $2.60 | $158,761.00 | 18% 338.09K to 399.15K | |
| 20-Aug-13 5:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 16-Aug-13 | Market Option Sale (Planned) | 61,062 | $34.04 | $2,078,550.00 | (15%) 399.15K to 338.09K | 98% |
| 12-Jun-13 4:01 PM View: | Acorda Therapeutics, Inc. (ACOR) | 10-Jun-13 | Market Sale (Planned) | 11,000 | $34.15 | $375,650.00 | (3%) 349.09K to 338.09K | 98% |
| 08-Mar-13 7:04 AM View: | Acorda Therapeutics, Inc. (ACOR) | 06-Mar-13 | Grant | 22,500 | -- | -- | 7% 326.59K to 349.09K | |
| 05-Dec-12 4:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Dec-12 | Market Sale (Planned) | 16,407 | $24.22 | $397,415.00 | (5%) 343.0K to 326.59K | 97% |
| 19-Mar-12 4:01 PM View: | Acorda Therapeutics, Inc. (ACOR) | 15-Mar-12 | Grant | 37,500 | -- | -- | 12% 305.5K to 343.0K | |
| 05-Dec-11 3:54 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-11 | Market Sale (Planned) | 16,500 | $22.92 | $378,180.00 | (5%) 322.0K to 305.5K | 97% |
| 09-Jun-11 4:35 PM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Jun-11 | Market Sale (Planned) | 12,000 | $30.87 | $370,440.00 | (4%) 334.0K to 322.0K | 98% |
| 31-May-11 4:07 PM View: | Acorda Therapeutics, Inc. (ACOR) | 26-May-11 | Option Exercise | 60,000 | $2.60 | $156,000.00 | 18% 334.0K to 394.0K | |
| 31-May-11 4:07 PM View: | Acorda Therapeutics, Inc. (ACOR) | 26-May-11 | Market Option Sale (Planned) | 60,000 | $32.58 | $1,954,800.00 | (15%) 394.0K to 334.0K | 98% |
| 19-Apr-11 4:03 PM View: | Acorda Therapeutics, Inc. (ACOR) | 18-Apr-11 | Option Exercise | 60,000 | $2.60 | $156,000.00 | 18% 334.0K to 394.0K | |
| 19-Apr-11 4:03 PM View: | Acorda Therapeutics, Inc. (ACOR) | 18-Apr-11 | Market Option Sale (Planned) | 60,000 | $28.24 | $1,694,400.00 | (15%) 394.0K to 334.0K | 97% |